Hyperthyroidism: Diagnosis and Treatment.
Mounsey A, Paulus R, Roten W.
Am Fam Physician. 2025 Aug;112(2):146-152.
Bilateral Keratoconus Induced by Secondary Hypothyroidism After Radioactive Iodine Therapy.
Lee R, Hafezi F, Randleman JB.
J Refract Surg. 2018 May 1;34(5):351-353. doi: 10.3928/1081597X-20171031-02.
Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves' disease in different periods.
Zhao A, Zhang J, Xue J, Lu X, Wang Q, Ji T, Yang L, Yu Y, Yang A.
Sci Rep. 2024 Dec 28;14(1):31148. doi: 10.1038/s41598-024-82521-5.
Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.
Bartalena L, Gallo D, Tanda ML, Kahaly GJ.
Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S2-S8. doi: 10.1097/IOP.0000000000002467. Epub 2023 Dec 4.
Early Sialadenitis After Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Prevalence and Predictors.
Riachy R, Ghazal N, Haidar MB, Elamine A, Nasrallah MP.
Int J Endocrinol. 2020 Aug 4;2020:8649794. doi: 10.1155/2020/8649794. eCollection 2020.
Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease.
Kim MJ, Cho SW, Kim YA, Choi HS, Park YJ, Park DJ, Cho BY.
Endocrinol Metab (Seoul). 2022 Jun;37(3):524-532. doi: 10.3803/EnM.2022.1418. Epub 2022 Jun 16.
Outcomes of Radioactive Iodine ((131)I) Therapy among Hyperthyroid patients.
Khan MSA, Hussain A, Ahmad S, Shah MH.
Pak J Med Sci. 2023 Nov-Dec;39(6):1685-1689. doi: 10.12669/pjms.39.6.7567.
Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study.
Mahmoud HA, Alsanory AAAA, Mostafa HG, Hassan ER.
Nucl Med Commun. 2024 Jun 1;45(6):499-509. doi: 10.1097/MNM.0000000000001838. Epub 2024 Apr 2.
Exploring the Link Between Thyroid Disorders and Obesity: Mechanisms, Impacts, and Clinical Implications.
Dharia A, Desai D, Desai K.
Endocr Pract. 2025 May;31(5):660-667. doi: 10.1016/j.eprac.2025.02.005. Epub 2025 Feb 12.
Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
Hu RT, Liu DS, Li B.
BMC Endocr Disord. 2020 May 29;20(1):76. doi: 10.1186/s12902-020-00557-w.
